For 77 years, Windlas family has been in business. Our journey has been exciting and rewarding with a successful track record of different products, customers and teams.
Windlas Biotech was born in year 2000 as the family revived a shutdown manufacturing facility after purchasing the same from financial institutions. Over the past two decades, Windlas has evolved into a fully integrated partner providing products and services to leading pharmaceutical companies. It has also created its own branded products that are distributed through its rapidly growing distribution network of more than 500 wholesalers across India.
2001
Plant 1 established and production started
2007
Set up of own brand (Marketing Division)
2009
Ventured into the International Markets. Crossed Rs 100 Cr revenue
by establishing a Windlas Healthcare plant
2014
Plant 2 set up comissioned and crossed Rs. 200 Cr.
1st USFDA inspection cleared for Windlas Healthcare plant
2015
Received private equity investment from Tano Capital
2016
Crossed Rs. 300 Cr. turnover.
2017
Plant 3 set up completed. Launched 1st product in US from WHC
2018
23 Million Dollar investment from Zydus in WHC
2019
Buyback of Zydus’ share in Windlas Healthcare